PEOPLE - Atos Consulting makes appointment:
This article was originally published in Clinica
Atos Consulting, the business consulting arm of Atos Origin, the French group that is poised to be a significant player in the UK's outsourced diagnostics services (see Clinica No 1224, p 5), has appointed Lesley McLay as senior consultant on its UK healthcare team. The focus of her more than 20 years' experience in the industry has been as consultant to national and local NHS bodies and, previously, through a number of NHS board directorships.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.